Abstract

Cancers of the brain and nervous system affect both adults and children, and come in several different forms. The cause of these cancers is not yet well understood. Although Significant advances have been made in understanding the biology of these cancers-as well As in tumor diagnosis, treatments, and quality of life of patients with the disease-the Mortality rate has remained steady for more than 30years.The 2021 World cancer Leaders' Summit is being hosted by the American Society for Clinical Pathology (ASCP) on 25th and 26thOctober2021, around the world virtually. Innovation to advance cancer control equitably’. “Interferon Genes drug injected directly into the glioblastoma of five dogs that had previously be undiagnosed with the cancer, which is the second-most common type of brain cancer in dogs. STING agonists can induce immunological responses that allow the immune system of fight otherwise immunologically resistant cancer cells. MRIs cans taken of the patients over the course of the 10-month trial revealed that some of The dogs, even with a single dose, responded to the treatment with apparent reductions in Their tumor volume, including one complete response in which the tumor appeared to Completely disappear, leading the team to conclude that this therapy can trigger robust, In Nate antitumor immune response and may be highly effective on recalcitrant tumors such as glioblastoma."With this therapy, we were trying to take tumors that do not, on their own, generate a lot of Immune response and turn the Minot tumors that do by injecting them with this immune therapy This clinical trial was base done earlier research by the team-including Dr. Jonathan Levine, a neurology professor and head of the CV MBS' Small Animal Clinical Sciences Department(VLCS)which analysed a massive can in genomic at a set collected from Multiple gliomas samples. They found that can in end human gliomas are molecularly similar, suggesting